Host defense peptides in wound healing

被引:135
作者
Steinstraesser, Lars [1 ]
Koehler, Till [2 ]
Jacobsen, Frank [1 ]
Daigeler, Adrien [1 ]
Goertz, Ole [1 ]
Langer, Stefan [1 ]
Kesting, Marco [3 ]
Steinau, Hans [1 ]
Eriksson, Elof [2 ]
Hirsch, Tobias [1 ,2 ]
机构
[1] Ruhr Univ Bochum, Dept Plast Surg, Burn Ctr, BG Univ Hosp Bergmannsheil, D-44789 Bochum, Germany
[2] Harvard Univ, Cambridge, MA 02138 USA
[3] Tech Univ Munich, D-8000 Munich, Germany
关键词
D O I
10.2119/2008-00002.Steinstraesser
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Host defense peptides are effector molecules of the innate immune system, They show broad antimicrobial action against gram-positive and -negative bacteria, and they likely play a key role in activating and mediating the innate as well as adaptive immune response in infection and inflammation. These features make them of high interest for wound healing research. Non-healing and infected wounds are a major problem in patient care and health care spending. Increasing infection rates, growing bacterial resistance to common antibiotics, and the lack of effective therapeutic options for the treatment of problematic wounds emphasize the need for new approaches in therapy and pathophysiologic understanding, This review focuses on the current knowledge of host defense peptides affecting wound healing and infection. We discuss the current data and highlight the potential future developments in this field of research.
引用
收藏
页码:528 / 537
页数:10
相关论文
共 188 条
[91]   Regulation of human β-defensin-2 in gingival epithelial cells:: The involvement of mitogen-activated protein kinase pathways, but not the NF-κB transcription factor family [J].
Krisanaprakornkit, S ;
Kimball, JR ;
Dale, BA .
JOURNAL OF IMMUNOLOGY, 2002, 168 (01) :316-324
[92]   Impairment of innate immune killing mechanisms by bacteriostatic antibiotics [J].
Kristian, Sascha A. ;
Timmer, Anjuli M. ;
Liu, George Y. ;
Lauth, Xavier ;
Sal-Man, Neta ;
Rosenfeld, Yosef ;
Shai, Yechiel ;
Gallo, Richard L. ;
Nizet, Victor .
FASEB JOURNAL, 2007, 21 (04) :1107-1116
[93]  
LARRICK JW, 1994, J IMMUNOL, V152, P231
[94]   HUMAN CAP18 - A NOVEL ANTIMICROBIAL LIPOPOLYSACCHARIDE-BINDING PROTEIN [J].
LARRICK, JW ;
HIRATA, M ;
BALINT, RF ;
LEE, J ;
ZHONG, J ;
WRIGHT, SC .
INFECTION AND IMMUNITY, 1995, 63 (04) :1291-1297
[95]   DEFENSINS - ANTIMICROBIAL AND CYTOTOXIC PEPTIDES OF MAMMALIAN-CELLS [J].
LEHRER, RI ;
LICHTENSTEIN, AK ;
GANZ, T .
ANNUAL REVIEW OF IMMUNOLOGY, 1993, 11 :105-128
[96]   MODULATION OF THE INVITRO CANDIDACIDAL ACTIVITY OF HUMAN NEUTROPHIL DEFENSINS BY TARGET CELL METABOLISM AND DIVALENT CATIONS [J].
LEHRER, RI ;
GANZ, T ;
SZKLAREK, D ;
SELSTED, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (06) :1829-1835
[97]   Defensins of vertebrate animals [J].
Lehrer, RI ;
Ganz, T .
CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (01) :96-102
[98]   INTERACTION OF HUMAN DEFENSINS WITH ESCHERICHIA-COLI - MECHANISM OF BACTERICIDAL ACTIVITY [J].
LEHRER, RI ;
BARTON, A ;
DAHER, KA ;
HARWIG, SSL ;
GANZ, T ;
SELSTED, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (02) :553-561
[99]   DEFENSINS - ENDOGENOUS ANTIBIOTIC PEPTIDES OF ANIMAL-CELLS [J].
LEHRER, RI ;
GANZ, T ;
SELSTED, ME .
CELL, 1991, 64 (02) :229-230
[100]   New insights into atopic dermatitis [J].
Leung, DYM ;
Boguniewicz, M ;
Howell, MD ;
Nomura, I ;
Hamid, OA .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (05) :651-657